NO20042440L - Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib - Google Patents

Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib

Info

Publication number: NO20042440L
Authority: NO; Norway
Prior art keywords: parecoxib; dosage form; oral dosage; sulfonamide; prodrug
Prior art date: 2001-11-13

Application number

NO20042440A

Other languages

English (en)

Norwegian (no)

Inventor

Aziz Karim

Sandeep Nema

Gary D Ewing

Original Assignee

Pharmacia Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-13

Filing date

2004-06-11

Publication date

2004-08-09

2004-06-11 Application filed by Pharmacia Corp filed Critical Pharmacia Corp

2004-08-09 Publication of NO20042440L publication Critical patent/NO20042440L/no

Links

239000006186 oral dosage form Substances 0.000 title 1
TZRHLKRLEZJVIJ-UHFFFAOYSA-N parecoxib Chemical compound C1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C(C)ON=C1C1=CC=CC=C1 TZRHLKRLEZJVIJ-UHFFFAOYSA-N 0.000 title 1
229960004662 parecoxib Drugs 0.000 title 1
239000000651 prodrug Substances 0.000 title 1
229940002612 prodrug Drugs 0.000 title 1
229940124530 sulfonamide Drugs 0.000 title 1
150000003456 sulfonamides Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20042440A 2001-11-13 2004-06-11 Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib NO20042440L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35059601P	2001-11-13	2001-11-13
PCT/US2002/036253 WO2003041705A1 (en)	2001-11-13	2002-11-12	Oral dosage form of a sulfonamide prodrug such as parecoxib

Publications (1)

Publication Number	Publication Date
NO20042440L true NO20042440L (no)	2004-08-09

Family

ID=23377399

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042440A NO20042440L (no)	2001-11-13	2004-06-11	Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib

Country Status (20)

Country	Link
US (1)	US20030100595A1 (de)
EP (1)	EP1446118B1 (de)
JP (1)	JP2005509002A (de)
KR (1)	KR20050044459A (de)
CN (1)	CN1615135A (de)
AR (1)	AR037356A1 (de)
AT (1)	ATE383156T1 (de)
BR (1)	BR0214081A (de)
CA (1)	CA2466504A1 (de)
CO (1)	CO5580744A2 (de)
DE (1)	DE60224558T2 (de)
ES (1)	ES2297032T3 (de)
IL (1)	IL161991A0 (de)
MX (1)	MXPA04004476A (de)
NO (1)	NO20042440L (de)
PL (1)	PL369962A1 (de)
RU (1)	RU2004114552A (de)
TW (1)	TW200300680A (de)
WO (1)	WO2003041705A1 (de)
ZA (1)	ZA200403328B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7785640B2 (en) *	2004-01-16	2010-08-31	Amerilab Technologies, Inc.	Effervescent composition including cranberry extract
SI2801354T1 (sl)	2004-10-08	2017-07-31	Forward Pharma A/S	Farmacevtske sestave z nadzorovanim sproščanjem, ki zajemajo ester fumarne kisline
CA2622286A1 (en) *	2005-09-27	2007-04-05	University Of Kentucky Research Foundation	Anti-inflammatory composition comprising berry extract
WO2007042035A2 (en) *	2005-10-07	2007-04-19	Aditech Pharma Ab	Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
US20100047371A1 (en) *	2006-08-29	2010-02-25	Mumper Russell J	Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
EP1902708A1 (de)	2006-09-25	2008-03-26	Losan Pharma GmbH	Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
EP2209501B1 (de) *	2007-10-12	2011-12-14	AstraZeneca AB	Zibotentan Zusammensetzung mit Mannitol und Mikrokristalliner Zellulose
KR101699912B1 (ko)	2009-01-09	2017-01-25	포워드 파마 에이/에스	1종 이상의 푸마르산 에스테르를 침식 매트릭스에 함유하는 제제
JP6102120B2 (ja) *	2012-08-16	2017-03-29	ニプロ株式会社	医薬製剤およびその製造方法
CN104771370B (zh) *	2014-01-14	2020-07-24	南京圣和药业股份有限公司	帕瑞昔布钠冻干粉针剂及其制备方法
CN104965041B (zh) *	2015-06-11	2016-06-29	成都克莱蒙医药科技有限公司	一种帕瑞昔布钠异构体的高效液相色谱检测方法
CN106074399B (zh) *	2016-06-21	2018-11-02	马鞍山丰原制药有限公司	一种帕瑞昔布钠冻干制剂及其制备方法
CN112409283A (zh) *	2020-11-24	2021-02-26	苏州璞正医药有限公司	一种帕瑞昔布衍生物及其制备方法和应用
WO2024208166A1 (zh) *	2023-04-04	2024-10-10	上海汇伦医药股份有限公司	西维来司他用于镇痛的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995013794A1 (en) *	1993-11-18	1995-05-26	Nippon Shinyaku Co., Ltd.	Process for producing stable medicinal composition, and pharmaceutical preparation
GB9523833D0 (en) *	1995-11-22	1996-01-24	Boots Co Plc	Medical treatment
WO1997038986A1 (en) *	1996-04-12	1997-10-23	G.D. Searle & Co.	Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
SE9703693D0 (sv) *	1997-10-10	1997-10-10	Astra Pharma Prod	Novel combination
US6323226B1 (en) *	1999-10-19	2001-11-27	Texas Heart Institute	Treatment of heart disease with cox-2 inhibitors
CA2362816C (en) *	1999-12-08	2007-02-06	Pharmacia Corporation	Valdecoxib compositions
ES2258988T3 (es) *	1999-12-22	2006-09-16	Pharmacia Corporation	Composiciones de liberacion dual de un inhibidor de la ciclooxigenasa-2.
ATE295832T1 (de) *	2000-03-24	2005-06-15	Pharmacia Corp	Amidino-verbindung sowie salze davon verwendbar als hemmstoffe der stickstoffmonoxid-synthase
MY120279A (en) *	2000-05-26	2005-09-30	Pharmacia Corp	Use of a celecoxib composition for fast pain relief
US6306842B1 (en) *	2000-06-02	2001-10-23	Medinox, Inc.	Protected forms of a combination of pharmacologically active agents and uses therefor
AU2001282886A1 (en) *	2000-07-13	2002-01-30	Pharmacia Corporation	Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
PE20021017A1 (es) *	2001-04-03	2002-11-24	Pharmacia Corp	Composicion parenteral reconstituible

2002
- 2002-11-12 US US10/292,682 patent/US20030100595A1/en not_active Abandoned
- 2002-11-12 RU RU2004114552/14A patent/RU2004114552A/ru not_active Application Discontinuation
- 2002-11-12 CN CNA028270843A patent/CN1615135A/zh active Pending
- 2002-11-12 AT AT02789593T patent/ATE383156T1/de not_active IP Right Cessation
- 2002-11-12 MX MXPA04004476A patent/MXPA04004476A/es active IP Right Grant
- 2002-11-12 TW TW091133146A patent/TW200300680A/zh unknown
- 2002-11-12 BR BR0214081-0A patent/BR0214081A/pt not_active IP Right Cessation
- 2002-11-12 CA CA002466504A patent/CA2466504A1/en not_active Abandoned
- 2002-11-12 AR ARP020104341A patent/AR037356A1/es unknown
- 2002-11-12 DE DE60224558T patent/DE60224558T2/de not_active Expired - Fee Related
- 2002-11-12 PL PL02369962A patent/PL369962A1/xx not_active Application Discontinuation
- 2002-11-12 JP JP2003543592A patent/JP2005509002A/ja active Pending
- 2002-11-12 KR KR1020047007335A patent/KR20050044459A/ko not_active Ceased
- 2002-11-12 WO PCT/US2002/036253 patent/WO2003041705A1/en not_active Ceased
- 2002-11-12 IL IL16199102A patent/IL161991A0/xx unknown
- 2002-11-12 EP EP02789593A patent/EP1446118B1/de not_active Expired - Lifetime
- 2002-11-12 ES ES02789593T patent/ES2297032T3/es not_active Expired - Lifetime
2004
- 2004-05-03 ZA ZA200403328A patent/ZA200403328B/en unknown
- 2004-05-07 CO CO04042439A patent/CO5580744A2/es not_active Application Discontinuation
- 2004-06-11 NO NO20042440A patent/NO20042440L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MXPA04004476A (es)	2004-08-11
WO2003041705A1 (en)	2003-05-22
ATE383156T1 (de)	2008-01-15
KR20050044459A (ko)	2005-05-12
CA2466504A1 (en)	2003-05-22
CO5580744A2 (es)	2005-11-30
EP1446118B1 (de)	2008-01-09
EP1446118A1 (de)	2004-08-18
IL161991A0 (en)	2005-11-20
PL369962A1 (en)	2005-05-02
ES2297032T3 (es)	2008-05-01
BR0214081A (pt)	2004-09-28
US20030100595A1 (en)	2003-05-29
TW200300680A (en)	2003-06-16
RU2004114552A (ru)	2005-02-20
ZA200403328B (en)	2005-04-13
DE60224558D1 (de)	2008-02-21
CN1615135A (zh)	2005-05-11
DE60224558T2 (de)	2009-01-22
AR037356A1 (es)	2004-11-03
JP2005509002A (ja)	2005-04-07

Legal Events

Date	Code	Title	Description
2006-07-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ATE296619T1 (de)	2005-06-15	Feste orale dosierungsform von simethicon
CY2013036I2 (el)	2015-12-09	Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
CY2018005I2 (el)	2018-06-27	Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DK1414409T3 (da)	2007-06-11	Stabiliseret oral suspensionsformulering
NO20033343L (no)	2003-09-24	Farmasöytiske doseringsformer av epothiloner for oral administrasjon
ITMI20021876A1 (it)	2004-03-04	Procedimento migliorato per realizzare un rotore di un
DE60307379D1 (de)	2006-09-21	Ausfallsichere filmgekühlte Wand
DK1545475T3 (da)	2014-07-28	Enterisk sammensætning til fremstillingen af blød kapselvæg
ATE380544T1 (de)	2007-12-15	Umhüllte feste darreichungsform
EE05581B1 (et)	2012-10-15	Aripiprasooli ravimlahus peroraalseks manustamiseks
SI1379220T1 (sl)	2005-04-30	Inhalacijske kapsule
NO20052474D0 (no)	2005-05-23	Amort form av esomeprazolsalter
IS7177A (is)	2004-03-11	Valdekoxíb samsetningar sem leysast upp í munni
IL161991A0 (en)	2005-11-20	Oral dosage form of a sulfonamide prodrug such as parecoxib
NO20040860L (no)	2004-04-22	Farmasoytisk sammensetning som innbefatter lumiracoxib
NO20034556D0 (no)	2003-10-10	Imidazotriazinon-holdige sammensetninger for nasal administrering
FI20000780A0 (fi)	2000-04-03	Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
NO20055612D0 (no)	2005-11-25	Anti-inflammatoriske fosfonatforbindelser
IS7219A (is)	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð
DK1446107T3 (da)	2014-11-03	Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
NO20043007L (no)	2004-07-15	Farmasoytisk suspensjon for oral administrering
NO20040857L (no)	2004-04-19	Ny oral forlenget frigivelses doseringsform.
DK1474114T3 (da)	2010-04-12	Oral doseringsform til reguleret frigivelse af et lægemiddel
NO20035547D0 (no)	2003-12-12	Fremgangsmåte for fremstilling av paroksetin HCl som begrenser dannelse avrosafargede forbindelser
DK1515959T3 (da)	2009-11-02	Farmaceutiske salte af reboxetin